164 related articles for article (PubMed ID: 31548507)
1. Investigation of Phospholipase Cγ1 Interaction with SLP76 Using Molecular Modeling Methods for Identifying Novel Inhibitors.
Tripathi N; Vetrivel I; Téletchéa S; Jean M; Legembre P; Laurent AD
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31548507
[TBL] [Abstract][Full Text] [Related]
2. Molecular design and optimization of hepatic cancer SLP76-derived PLCγ1 SH3-binding peptide with the systematic N-substitution of peptide PXXP motif.
Tang W; Zhao Z; Wang C; Ye T; Yang B
J Mol Recognit; 2019 Dec; 32(12):e2806. PubMed ID: 31397025
[TBL] [Abstract][Full Text] [Related]
3. Competition between SLP76 and LAT for PLCγ1 binding in resting T cells.
Jung SH; Jeong JH; Seul HJ; Lee JR
Eur J Immunol; 2010 Aug; 40(8):2330-9. PubMed ID: 20544725
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for recognition of the T cell adaptor protein SLP-76 by the SH3 domain of phospholipase Cgamma1.
Deng L; Velikovsky CA; Swaminathan CP; Cho S; Mariuzza RA
J Mol Biol; 2005 Sep; 352(1):1-10. PubMed ID: 16061254
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase Cepsilon may act as EGF-inducible scaffold protein for phospholipase Cgamma1.
Valkova C; Maerz S; Imhof D; Liebmann C
Cell Signal; 2007 Sep; 19(9):1830-43. PubMed ID: 17561374
[TBL] [Abstract][Full Text] [Related]
6. Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.
Wu C; Ma MH; Brown KR; Geisler M; Li L; Tzeng E; Jia CY; Jurisica I; Li SS
Proteomics; 2007 Jun; 7(11):1775-85. PubMed ID: 17474147
[TBL] [Abstract][Full Text] [Related]
7. Identifying hQC Inhibitors of Alzheimer's Disease by Effective Customized Pharmacophore-Based Virtual Screening, Molecular Dynamic Simulation, and Binding Free Energy Analysis.
Lin W; Zheng X; Fang D; Zhou S; Wu W; Zheng K
Appl Biochem Biotechnol; 2019 Apr; 187(4):1173-1192. PubMed ID: 30187344
[TBL] [Abstract][Full Text] [Related]
8. Disrupting the CD95-PLCγ1 interaction prevents Th17-driven inflammation.
Poissonnier A; Guégan JP; Nguyen HT; Best D; Levoin N; Kozlov G; Gehring K; Pineau R; Jouan F; Morere L; Martin S; Thomas M; Lazaro E; Douchet I; Ducret T; van de Weghe P; Blanco P; Jean M; Vacher P; Legembre P
Nat Chem Biol; 2018 Dec; 14(12):1079-1089. PubMed ID: 30429604
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel inhibitors of Mycobacterium tuberculosis MurG: homology modelling, structure based pharmacophore, molecular docking, and molecular dynamics simulations.
Saxena S; Abdullah M; Sriram D; Guruprasad L
J Biomol Struct Dyn; 2018 Sep; 36(12):3184-3198. PubMed ID: 28948866
[TBL] [Abstract][Full Text] [Related]
10. A Small Molecule Inhibitor of PDK1/PLCγ1 Interaction Blocks Breast and Melanoma Cancer Cell Invasion.
Raimondi C; Calleja V; Ferro R; Fantin A; Riley AM; Potter BV; Brennan CH; Maffucci T; Larijani B; Falasca M
Sci Rep; 2016 May; 6():26142. PubMed ID: 27199173
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationship of pentacylic triterpene esters from Uncaria rhynchophylla as inhibitors of phospholipase Cgamma1.
Lee JS; Yoo H; Suh YG; Jung JK; Kim J
Planta Med; 2008 Oct; 74(12):1481-7. PubMed ID: 18816430
[TBL] [Abstract][Full Text] [Related]
12. Virtual screening of small molecules databases for discovery of novel PARP-1 inhibitors: combination of in silico and in vitro studies.
Ekhteiari Salmas R; Unlu A; Bektaş M; Yurtsever M; Mestanoglu M; Durdagi S
J Biomol Struct Dyn; 2017 Jul; 35(9):1899-1915. PubMed ID: 27315035
[TBL] [Abstract][Full Text] [Related]
13. Exploration of New and Potent Lead Molecules Against CAAX Prenyl Protease I of Leishmania donovani Through Pharmacophore Based Virtual Screening Approach.
Prabhu SV; Tiwari K; Suryanarayanan V; Dubey VK; Singh SK
Comb Chem High Throughput Screen; 2017; 20(3):255-271. PubMed ID: 28116998
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of peptidomimetics and chemo-biological tools for CD95/PLCγ1 interaction analysis.
Nguyen HT; Guégan JP; Poissonnier A; Jouan F; Best D; van de Weghe P; Vacher P; Levoin N; Legembre P; Jean M
Bioorg Med Chem Lett; 2019 Aug; 29(16):2094-2099. PubMed ID: 31301931
[TBL] [Abstract][Full Text] [Related]
15. Recruitment and activation of PLCgamma1 in T cells: a new insight into old domains.
Braiman A; Barda-Saad M; Sommers CL; Samelson LE
EMBO J; 2006 Feb; 25(4):774-84. PubMed ID: 16467851
[TBL] [Abstract][Full Text] [Related]
16. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.
Iqbal S; Anantha Krishnan D; Gunasekaran K
J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053
[TBL] [Abstract][Full Text] [Related]
17. Multimodal Recognition of Diverse Peptides by the C-Terminal SH2 Domain of Phospholipase C-γ1 Protein.
McKercher MA; Guan X; Tan Z; Wuttke DS
Biochemistry; 2017 Apr; 56(16):2225-2237. PubMed ID: 28376302
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel Plasmodium falciparum PI4KB inhibitors as potential anti-malarial drugs: Homology modeling, molecular docking and molecular dynamics simulations.
Ibrahim MAA; Abdelrahman AHM; Hassan AMA
Comput Biol Chem; 2019 Jun; 80():79-89. PubMed ID: 30928871
[TBL] [Abstract][Full Text] [Related]
19. Phospholipase Cγ1 Mediates Intima Formation Through Akt-Notch1 Signaling Independent of the Phospholipase Activity.
Jiang D; Zhuang J; Peng W; Lu Y; Liu H; Zhao Q; Chi C; Li X; Zhu G; Xu X; Yan C; Xu Y; Ge J; Pang J
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28698260
[TBL] [Abstract][Full Text] [Related]
20. Probing the side chain tolerance for inhibitors of the CD95/PLCγ1 interaction.
Nguyen HT; Guégan JP; Best D; van de Weghe P; Levoin N; Legembre P; Jean M
Bioorg Med Chem Lett; 2019 Nov; 29(21):126669. PubMed ID: 31526605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
